Literature DB >> 8415342

Anterior pituitary function after adrenalectomy in patients with Cushing's syndrome.

M Marazuela1, C Cuerda, T Lucas, A Vicente, C Blanco, J Estrada.   

Abstract

We assessed anterior pituitary function in five patients with Cushing's syndrome before and after the removal of cortisol-secreting adrenal adenomas. Before surgery, all patients lacked response of growth hormone to hypoglycaemia, four had low responses of thyrotrophin to thyrotrophin releasing hormone, three had hypogonadism and two had low prolactin reserve. After successful removal of the adrenal adenoma, all patients developed postoperative hypoadrenocorticism and recovered all impaired anterior pituitary hormones within a period of 3 months. Our results point to a direct inhibiting action of glucocorticoids at the pituitary level as the explanation for the impaired anterior pituitary function. Moreover, direct gonadal suppression by glucocorticoids may be an additional mechanism of hypogonadism in some patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415342      PMCID: PMC2399881          DOI: 10.1136/pgmj.69.813.547

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  19 in total

1.  EFFECT OF CORTICOSTEROIDS ON SERUM GROWTH HORMONE.

Authors:  M HARTOG; M A GAAFAR; R FRASER
Journal:  Lancet       Date:  1964-08-22       Impact factor: 79.321

2.  Reversible panhypopituitarism due to Cushing's syndrome.

Authors:  K Watanabe; A Adachi; R Nakamura
Journal:  Arch Intern Med       Date:  1988-06

3.  Responses of plasma ACTH, GH, LH and 11-hydroxycorticosteroids to various stimuli in patients with Cushing's syndrome.

Authors:  R Demura; H Demura; T Nunokawa; H Baba; K Miura
Journal:  J Clin Endocrinol Metab       Date:  1972-05       Impact factor: 5.958

4.  Effect of glucocorticoids on plasma growth hormone in man.

Authors:  J N Stiel; D P Island; G W Liddle
Journal:  Metabolism       Date:  1970-02       Impact factor: 8.694

5.  Growth hormone and cortisol responsiveness in Cushing's syndrome. Relation to a possible central nervous system etiology.

Authors:  D T Krieger; S M Glick
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

6.  Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome.

Authors:  A A Kasperlik-Zaluska; W Jeske
Journal:  Acta Endocrinol (Copenh)       Date:  1980-03

7.  Pituitary function after removal of pituitary microadenomas in Cushing's disease.

Authors:  A M Schnall; J S Brodkey; B Kaufman; O H Pearson
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

8.  Anterior pituitary function in Cushing's syndrome: study of 36 patients.

Authors:  C Cuerda; J Estrada; M Marazuela; A Vicente; B Astigarraga; I Bernabeu; S Diez; L Salto
Journal:  Endocrinol Jpn       Date:  1991-10

9.  Studies on pituitary-gonadal function in patients with Cushing's syndrome.

Authors:  E Odagiri; Y Yamanaka; N Ishiwatari; K Jibiki; R Demura; H Demura; T Suda; K Shizume
Journal:  Endocrinol Jpn       Date:  1988-06

10.  Gonadotrophin levels in women with Cushing's syndrome before and after treatment.

Authors:  M C White; J Sanderson; K Mashiter; G F Joplin
Journal:  Clin Endocrinol (Oxf)       Date:  1981-01       Impact factor: 3.478

View more
  2 in total

Review 1.  Testosterone replacement therapy: role of pituitary and thyroid in diagnosis and treatment.

Authors:  Megan Crawford; Laurence Kennedy
Journal:  Transl Androl Urol       Date:  2016-12

Review 2.  Small cell lung cancer with panhypopituitarism due to ectopic adrenocorticotropic hormone syndrome: A case report.

Authors:  Ting Jin; Fang Wu; Shui-Ya Sun; Fen-Ping Zheng; Jia-Qiang Zhou; Yi-Ping Zhu; Zhou Wang
Journal:  World J Clin Cases       Date:  2019-05-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.